Journal
JOURNAL OF PEDIATRICS
Volume 136, Issue 5, Pages 682-687Publisher
MOSBY-ELSEVIER
DOI: 10.1067/mpd.2000.105355
Keywords
-
Categories
Funding
- NCI NIH HHS [KO8CA72587] Funding Source: Medline
Ask authors/readers for more resources
We report a child who developed autoimmune lymphoproliferative syndrome (ALPS) secondary to a heterozygous dominant negative mutation in the death domain of the Fas receptor. Previously developmentally normal, he had symptoms of autism with rapid regression in developmental milestones coincident with the onset of lymphoproliferation and autoimmune hemolytic anemia. Low-dose steroid therapy induced early and complete remission in the ALPS phenotype. There was subjective improvement, followed by objective improvement in speech and developmental milestones. We propose that autism may be part of the autoimmune disease spectrum of ALPS in this child, and this case represents a novel manifestation and target organ involvement in this disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available